BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15122513)

  • 1. Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease.
    van der Walt JM; Noureddine MA; Kittappa R; Hauser MA; Scott WK; McKay R; Zhang F; Stajich JM; Fujiwara K; Scott BL; Pericak-Vance MA; Vance JM; Martin ER
    Am J Hum Genet; 2004 Jun; 74(6):1121-7. PubMed ID: 15122513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor 20 (FGF20) gene polymorphism and risk of Parkinson's disease: a meta-analysis.
    Zhu R; Zhu Y; Liu X; He Z
    Neurol Sci; 2014 Dec; 35(12):1889-94. PubMed ID: 24942208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene-gene interaction between FGF20 and MAOB in Parkinson disease.
    Gao X; Scott WK; Wang G; Mayhew G; Li YJ; Vance JM; Martin ER
    Ann Hum Genet; 2008 Mar; 72(Pt 2):157-62. PubMed ID: 18205889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of evidence for a genetic association between FGF20 and Parkinson's disease in Finnish and Greek patients.
    Clarimon J; Xiromerisiou G; Eerola J; Gourbali V; Hellström O; Dardiotis E; Peuralinna T; Papadimitriou A; Hadjigeorgiou GM; Tienari PJ; Singleton AB
    BMC Neurol; 2005 Jun; 5():11. PubMed ID: 15967032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor 20 gene and Parkinson's disease in the Japanese population.
    Satake W; Mizuta I; Suzuki S; Nakabayashi Y; Ito C; Watanabe M; Takeda A; Hasegawa K; Sakoda S; Yamamoto M; Hattori N; Murata M; Toda T
    Neuroreport; 2007 Jun; 18(9):937-40. PubMed ID: 17515805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor 20 polymorphism in sporadic Parkinson's disease in Northern Han Chinese.
    Xu X; Wang N; Xu H; Xie A; Jiang H; Xie J
    J Clin Neurosci; 2013 Nov; 20(11):1588-90. PubMed ID: 23938014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative assessment of the association between fibroblast growth factor 20 rs1721100 C/G polymorphism and the risk of sporadic Parkinson's diseases: a meta-analysis.
    Ma ZG; Xu J; Liu TW
    Neurol Sci; 2015 Jan; 36(1):47-51. PubMed ID: 25030126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor 20 (FGF20) polymorphism is a risk factor for Parkinson's disease in Chinese population.
    Pan J; Li H; Wang Y; Ma JF; Zhang J; Wang G; Liu J; Wang XJ; Xiao Q; Chen SD
    Parkinsonism Relat Disord; 2012 Jun; 18(5):629-31. PubMed ID: 22342445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of FGF 20 variants for susceptibility to Parkinson's disease in Eastern Indians.
    Sadhukhan D; Das G; Biswas A; Ghosh S; Das SK; Ray K; Ray J
    Neurosci Lett; 2018 May; 675():68-73. PubMed ID: 29604408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calbindin 1, fibroblast growth factor 20, and alpha-synuclein in sporadic Parkinson's disease.
    Mizuta I; Tsunoda T; Satake W; Nakabayashi Y; Watanabe M; Takeda A; Hasegawa K; Nakashima K; Yamamoto M; Hattori N; Murata M; Toda T
    Hum Genet; 2008 Aug; 124(1):89-94. PubMed ID: 18568448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein.
    Wang G; van der Walt JM; Mayhew G; Li YJ; Züchner S; Scott WK; Martin ER; Vance JM
    Am J Hum Genet; 2008 Feb; 82(2):283-9. PubMed ID: 18252210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative assessment of the effect of FGF20 rs1721100 and rs12720208 variant on the risk of sporadic Parkinson's disease: a meta-analysis.
    Quan W; Li J; Liu L; Zhang Q; Qin Y; Pei X; Chen J
    Neurol Sci; 2022 May; 43(5):3145-3152. PubMed ID: 34845561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of the rs12720208 single-nucleotide polymorphism of the FGF20 gene in Russian patients with sporadic Parkinson's disease].
    Ustinova VV; Shadrina MI; Fedotova EIu; Illarioshkin SN; Limborskaia SA; Slominskiĭ PA
    Genetika; 2012 Dec; 48(12):1437-9. PubMed ID: 23516905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in the miRNA-433 binding site of FGF20 is a risk factor for Parkinson's disease in Iranian population.
    Haghnejad L; Emamalizadeh B; Jamshidi J; Bidoki AZ; Ghaedi H; Ahmadi E; Abdollahi S; Shahmohammadibeni N; Taghavi S; Fazeli A; Motallebi M; Zarneh AE; Mohammadihosseinabad S; Abbaszadegan MR; Torkamandi S; Gavenaroudi MA; Pedram N; Shahidi GA; Tafakhori A; Darvish H; Movafagh A
    J Neurol Sci; 2015 Aug; 355(1-2):72-4. PubMed ID: 26070653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between FGF20 rs12720208 gene polymorphism and Parkinson's disease: a meta-analysis.
    Zhao X; Wu Y; Zhao C; Feng M
    Neurol Sci; 2016 Jul; 37(7):1119-26. PubMed ID: 27023076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease.
    Martin ER; Scott WK; Nance MA; Watts RL; Hubble JP; Koller WC; Lyons K; Pahwa R; Stern MB; Colcher A; Hiner BC; Jankovic J; Ondo WG; Allen FH; Goetz CG; Small GW; Masterman D; Mastaglia F; Laing NG; Stajich JM; Ribble RC; Booze MW; Rogala A; Hauser MA; Zhang F; Gibson RA; Middleton LT; Roses AD; Haines JL; Scott BL; Pericak-Vance MA; Vance JM
    JAMA; 2001 Nov; 286(18):2245-50. PubMed ID: 11710889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-nucleotide polymorphisms and haplotypes of non-coding area in the CP gene are correlated with Parkinson's disease.
    Zhao N; Xiao J; Zheng Z; Fei G; Zhang F; Jin L; Zhong C
    Neurosci Bull; 2015 Apr; 31(2):245-56. PubMed ID: 25758665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linkage disequilibrium and haplotype tagging polymorphisms in the Tau H1 haplotype.
    Oliveira SA; Scott WK; Zhang F; Stajich JM; Fujiwara K; Hauser M; Scott BL; Pericak-Vance MA; Vance JM; Martin ER
    Neurogenetics; 2004 Sep; 5(3):147-55. PubMed ID: 15459824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic evidence for ubiquitin-specific proteases USP24 and USP40 as candidate genes for late-onset Parkinson disease.
    Li Y; Schrodi S; Rowland C; Tacey K; Catanese J; Grupe A
    Hum Mutat; 2006 Oct; 27(10):1017-23. PubMed ID: 16917932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha-Synuclein and Parkinson disease susceptibility.
    Winkler S; Hagenah J; Lincoln S; Heckman M; Haugarvoll K; Lohmann-Hedrich K; Kostic V; Farrer M; Klein C
    Neurology; 2007 Oct; 69(18):1745-50. PubMed ID: 17872362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.